Aaron M. Fischman, MD

About

Program Director, Interventional Radiology Residency

Dr. Aaron M. Fischman, MD, FSIR, FCIRSE, FSVM, is Professor of Diagnostic, Molecular, and Interventional Radiology, Urology, and Surgery at the Icahn School of Medicine at Mount Sinai. He serves as Program Director for the Interventional Radiology Residency across the Mount Sinai Health System and is internationally recognized for his expertise in minimally invasive prostate interventions.

Dr. Fischman is Co-Leader of Mount Sinai’s TULSA Program, helping to advance incision-free, image-guided treatment options for patients with prostate cancer. A pioneer in prostate artery embolization (PAE) for men with benign prostatic hyperplasia (BPH), he helped establish Mount Sinai as a global leader in advanced prostate therapies. He was among the first in the United States to introduce transradial (wrist-based) access for prostate embolization, improving patient comfort, reducing recovery time, and enabling same-day discharge. He has also developed innovative methods using liquid embolics to shorten procedure duration and minimize radiation exposure.

Dr. Fischman continues to lead and participate in major multi-center clinical trials, including the BEST Trial, which compares embolization to traditional surgical treatment for BPH. He actively trains physicians worldwide in advanced image-guided prostate interventions and continues to drive innovation in minimally invasive men’s health care.